SHERWIN WILLIAMS CO |
Director |
Common Stock |
11.9K |
$4.42M |
$372.47 |
Oct 4, 2024 |
Direct |
REGENERON PHARMACEUTICALS, INC. |
Director |
Common Stock |
2.17K |
$2.52M |
$1,161.32 |
Aug 15, 2024 |
Direct |
PRUDENTIAL FINANCIAL INC |
Director |
Notional Shares - Mandatory |
12.5K |
$1.45M |
$115.84 |
Sep 12, 2024 |
Direct |
PRUDENTIAL FINANCIAL INC |
Director |
Common Stock |
11.6K |
$1.37M |
$117.95 |
May 9, 2024 |
Direct |
SHERWIN WILLIAMS CO |
Director |
Common Stock |
2.53K |
$944K |
$372.47 |
Oct 4, 2024 |
Deferred Fee Plan |
PRUDENTIAL FINANCIAL INC |
Director |
Notional Shares - Optional |
3.84K |
$445K |
$115.84 |
Sep 12, 2024 |
Direct |
NEUROCRINE BIOSCIENCES INC |
Director |
Non-Qualified Stock Option |
2.98K |
$219K |
$73.60 |
May 22, 2024 |
Direct |
NEUROCRINE BIOSCIENCES INC |
Director |
Restricted Stock Unit |
1.44K |
$204K |
$141.90 |
May 22, 2024 |
Direct |
PRUDENTIAL FINANCIAL INC |
Director |
2024 Restricted Stock Units |
1.29K |
$149K |
$115.84 |
Sep 12, 2024 |
Direct |
PRUDENTIAL FINANCIAL INC |
Director |
2023 Restricted Stock Units |
0 |
$0 |
$116.58 |
May 9, 2024 |
Direct |
REGENERON PHARMACEUTICALS, INC. |
Director |
Non-Qualified Stock Option (right to buy) |
1.61K |
|
|
Jan 2, 2024 |
Direct |
REGENERON PHARMACEUTICALS, INC. |
Director |
Non-Qualified Stock Option (right to buy) |
0 |
|
|
Aug 15, 2024 |
Direct |